Home › NDC Lookup › Drug shortages › Clonazepam Tablet

Clonazepam Tablet shortage

Clonazepam Tablet is currently listed in shortage by the FDA. The FDA lists 40 affected products. The reported reason: Other. This page was last refreshed from FDA data on Sep 28, 2026.

Current ⚠ Supply risk: Low Controlled substance Neurology, Pediatric, Psychiatry 40 products 6 manufacturers 1,298 days · 3.6 yr First posted Mar 10, 2023 Updated Sep 16, 2026
Here’s the bottom line

Clonazepam tablets are on the FDA shortage list, though all three strengths (0.5 mg, 1 mg, and 2 mg) still show available supply from all six reporting manufacturers. Orally disintegrating clonazepam tablets in several strengths are also listed by makers not reporting a shortage.

Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
40
Affected NDCs
6
Reporting manufacturers
6/6
Reporting mfrs supplying
3/3
Affected strengths supplied
0%
NDCs unavailable
1,298
Days in shortage
3,405,942
Medicaid Rx (2026)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Sep 28, 2026 · today

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Clonazepam Tablet. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
40 NDCs
Available 39 Limited 1
Affected strengths still supplied
Among manufacturers reporting this shortage
3/3 strengths
Sourceable 3
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
6/6 makers
With supply 6
✓ Other manufacturers not reporting a shortage
Still-marketed Clonazepam Tablet from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Teva Pharmaceuticals USA, Inc. Major Pharmaceuticals PD-Rx Pharmaceuticals, Inc. Par Health USA, LLC
See all other options & details →
Shortage timeline
  1. Sep 16, 2026
    Currently in shortage
    40 of 40 products affected.
  2. Sep 15, 2026
    FDA refreshed this shortage record
    11 products updated.
  3. Sep 2, 2026
    FDA refreshed this shortage record
    8 products updated.
  4. Aug 17, 2026
    FDA refreshed this shortage record
    1 product updated.
  5. Jun 2, 2026
    FDA refreshed this shortage record
    6 products updated.
  6. Jun 1, 2026
    FDA refreshed this shortage record
    11 products updated.
  7. Mar 27, 2023
    More presentations reported
    1 more product added to the shortage.
  8. Mar 10, 2023
    First reported to the FDA
    39 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Accord Healthcare Inc. 📞 866-941-7875, option 2 6 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Clonazepam, Tablet, 2 mg (NDC 16729-138-00) NDC 16729-0138-00 — Available — —
Current Clonazepam, Tablet, 1 mg (NDC 16729-137-00) NDC 16729-0137-00 — Available — —
Current Clonazepam, Tablet, 1 mg (NDC 16729-137-16) NDC 16729-0137-16 — Available — —
Current Clonazepam, Tablet, 2 mg (NDC 16729-138-16) NDC 16729-0138-16 — Available — —
Current Clonazepam, Tablet, .5 mg (NDC 16729-136-16) NDC 16729-0136-16 — Available — —
Current Clonazepam, Tablet, .5 mg (NDC 16729-136-00) NDC 16729-0136-00 — Available — —
Manufacturer: Aurobindo Pharma USA 📞 866-850-2876 6 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Clonazepam, Tablet, 2 mg (NDC 59651-724-05) NDC 59651-0724-05 — Available — —
Current Clonazepam, Tablet, 2 mg (NDC 59651-724-01) NDC 59651-0724-01 — Available — —
Current Clonazepam, Tablet, 1 mg (NDC 59651-723-01) NDC 59651-0723-01 — Available — —
Current Clonazepam, Tablet, 1 mg (NDC 59651-723-99) NDC 59651-0723-99 — Available — —
Current Clonazepam, Tablet, .5 mg (NDC 59651-722-99) NDC 59651-0722-99 — Available — —
Current Clonazepam, Tablet, .5 mg (NDC 59651-722-01) NDC 59651-0722-01 — Available — —
Manufacturer: Cheplapharm Arzneimittel GmbH 📞 [email protected] 3 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Klonopin, Tablet, 1 mg (NDC 61269-610-10) NDC 61269-0610-10 — Available Marketed by H2-Pharma —
Current Klonopin, Tablet, 2 mg (NDC 61269-620-10) NDC 61269-0620-10 — Available Marketed by H2-Pharma —
Current Klonopin, Tablet, .5 mg (NDC 61269-605-10) NDC 61269-0605-10 — Available Marketed by H2-Pharma —
Manufacturer: Prinston Pharmaceutical, Inc. 📞 For orders, Solco Healthcare 866-931-9829 8 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Clonazepam, Tablet, 1 mg (NDC 43547-407-11) NDC 43547-0407-11 — Available Marketed by Solco Healthcare —
Current Clonazepam, Tablet, 1 mg (NDC 43547-407-10) NDC 43547-0407-10 — Available Marketed by Solco Healthcare —
Current Clonazepam, Tablet, 2 mg (NDC 43547-408-50) NDC 43547-0408-50 — Available Marketed by Solco Healthcare —
Current Clonazepam, Tablet, .5 mg (NDC 43547-406-11) NDC 43547-0406-11 — Available Marketed by Solco Healthcare —
Current Clonazepam, Tablet, .5 mg (NDC 43547-406-50) NDC 43547-0406-50 — Available Marketed by Solco Healthcare —
Current Clonazepam, Tablet, 2 mg (NDC 43547-408-10) NDC 43547-0408-10 — Available Marketed by Solco Healthcare —
Current Clonazepam, Tablet, .5 mg (NDC 43547-406-10) NDC 43547-0406-10 — Available Marketed by Solco Healthcare —
Current Clonazepam, Tablet, 1 mg (NDC 43547-407-50) NDC 43547-0407-50 — Available Marketed by Solco Healthcare —
Manufacturer: Rubicon Research Private Limited 📞 [email protected] 11 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Clonazepam, Tablet, .5 mg (NDC 72888-152-05) NDC 72888-0152-05 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, 2 mg (NDC 72888-154-30) NDC 72888-0154-30 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, .5 mg (NDC 72888-152-01) NDC 72888-0152-01 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, 1 mg (NDC 72888-153-01) NDC 72888-0153-01 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, .5 mg (NDC 72888-152-30) NDC 72888-0152-30 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, .5 mg (NDC 72888-152-00) NDC 72888-0152-00 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, 1 mg (NDC 72888-153-30) NDC 72888-0153-30 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, 2 mg (NDC 72888-154-05) NDC 72888-0154-05 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, 1 mg (NDC 72888-153-00) NDC 72888-0153-00 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, 1 mg (NDC 72888-153-05) NDC 72888-0153-05 — Available Marketed by Advagen Pharma Ltd. —
Current Clonazepam, Tablet, 2 mg (NDC 72888-154-01) NDC 72888-0154-01 — Available Marketed by Advagen Pharma Ltd. —
Manufacturer: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 6 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Clonazepam, Tablet, .5 mg (NDC 0093-0832-01) NDC 00093-0832-01 — Available — —
Current Clonazepam, Tablet, 1 mg (NDC 0093-3212-05) NDC 00093-3212-05 — Available — —
Current Clonazepam, Tablet, 2 mg (NDC 0093-3213-05) NDC 00093-3213-05 — Available — —
Current Clonazepam, Tablet, 2 mg (NDC 0093-3213-01) NDC 00093-3213-01 — Available — —
Current Clonazepam, Tablet, .5 mg (NDC 0093-0832-05) NDC 00093-0832-05 — Available — —
Current Clonazepam, Tablet, 1 mg (NDC 0093-3212-01) NDC 00093-3212-01 — Limited Availability Estimated supply: August 2026 Other

These rows are manufacturer reports to the FDA for Clonazepam Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Clonazepam Tablet? options further down this page.

Why is Clonazepam Tablet in shortage?

The main thing to know here is that most clonazepam tablets on this FDA shortage report are actually showing as available right now. The one specific product with limited supply is Teva Pharmaceuticals' 1 mg clonazepam tablet (the 100-count bottle, NDC 0093-3212-01). Teva reported this under the broad category of "other" — meaning they didn't share a specific public reason for the tightness in supply. Their estimated timeline to have more of that particular package available is August 2026.

It's worth knowing that Teva's other clonazepam tablet strengths and package sizes — including their 0.5 mg and 2 mg tablets, as well as a different package of their 1 mg tablet — are listed as available. Again, this report only reflects what these specific manufacturers filed with the FDA, so it's a snapshot of their individual product inventories rather than a statement about every company that makes clonazepam.

FDA reason code(s): Other

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Clonazepam Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Clonazepam Tablet?

Clonazepam tablets are currently on the FDA shortage list. I want to reassure you right away: even though this shortage has been listed for over a year, all three strengths still have a source, and the overall supply risk is rated low.

Here is how the strengths look. The 0.5 mg, 1 mg, and 2 mg tablets all currently have an available source — none of the three strengths is without supply. All six manufacturers on this record are still reporting available product. One company (Teva) shows limited availability on its 1 mg tablet, with an estimated supply date of August 2026, but other makers list the 1 mg as available. The FDA lists the reason simply as "Other."

Because the shortage is limited and supply is broad, day-to-day disruption should be minimal. Still, please keep these steps in mind:

  • Do not stop, skip, or change your dose on your own.
  • Since your strength still has supply, ask your pharmacy to order it — they can check wholesalers and other manufacturers.
  • If your usual product is hard to find locally, your pharmacy may be able to source the same medicine from another maker, though it may not be in stock right away.
  • If you run into trouble, ask your prescriber or pharmacist about options.

Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is general national data and may not match your local pharmacy's actual stock.

See “Where else can I get Clonazepam Tablet?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
  • This is a controlled substance. Transfers between pharmacies and switching strengths have extra federal/state rules — ask the pharmacy before you assume a transfer is possible.
Keep reading
Our full Clonazepam guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Clonazepam guide →

Where else can I get Clonazepam Tablet?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Clonazepam Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Clonazepam CLONAZEPAM .125 mg/1 Tablet, Orally Disintegrating · Oral Teva Pharmaceuticals USA, Inc. 00093-9290-67
Clonazepam CLONAZEPAM .25 mg/1 Tablet, Orally Disintegrating · Oral Teva Pharmaceuticals USA, Inc. 00093-9291-67
Clonazepam CLONAZEPAM .5 mg/1 Tablet, Orally Disintegrating · Oral Teva Pharmaceuticals USA, Inc. 00093-9292-67
Clonazepam CLONAZEPAM 1 mg/1 Tablet, Orally Disintegrating · Oral Teva Pharmaceuticals USA, Inc. 00093-9293-67
Clonazepam CLONAZEPAM 2 mg/1 Tablet, Orally Disintegrating · Oral Teva Pharmaceuticals USA, Inc. 00093-9294-67
Clonazepam CLONAZEPAM .5 mg/1 Tablet · Oral Major Pharmaceuticals 00904-7227-61
Clonazepam CLONAZEPAM 1 mg/1 Tablet · Oral Major Pharmaceuticals 00904-7728-61
Clonazepam CLONAZEPAM 2 mg/1 Tablet · Oral PD-Rx Pharmaceuticals, Inc. 43063-0788-30
Clonazepam CLONAZEPAM 1 mg/1 Tablet · Oral PD-Rx Pharmaceuticals, Inc. 43063-0794-30
Clonazepam CLONAZEPAM .5 mg/1 Tablet · Oral PD-Rx Pharmaceuticals, Inc. 43063-0797-30
Clonazepam CLONAZEPAM .125 mg/1 Tablet, Orally Disintegrating · Oral Par Health USA, LLC 49884-0306-02
Clonazepam CLONAZEPAM .25 mg/1 Tablet, Orally Disintegrating · Oral Par Health USA, LLC 49884-0307-02
Therapeutic equivalents & pricing 30 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Clonazepam 1 mgNDC 00093-3212-01 Teva 100 tablets $0.024 AB Availability likely
Clonazepam 1 mgNDC 00904-7728-61 Major 100 tablets $0.024 AB Availability likely
Clonazepam 1 mgNDC 16729-0137-00 Accord 100 tablets $0.024 AB Availability likely
Clonazepam 1 mgNDC 43547-0407-10 Solco 100 tablets $0.024 AB Availability likely
Clonazepam 1 mgNDC 50268-0174-15 AvPAK 50 tablets $0.024 AB Availability likely
Clonazepam 1 mgNDC 59651-0723-01 Aurobindo 100 tablets $0.024 — Availability likely
Clonazepam 1 mgNDC 60687-0872-01 American 100 tablets $0.024 AB Availability likely
Clonazepam 1 mgNDC 62135-0770-90 Chartwell 90 tablets $0.024 AB Availability likely
Clonazepam 1 mgNDC 72603-0308-01 Northstar 100 tablets $0.024 — Availability likely
Clonazepam 1 mgNDC 72888-0153-00 Advagen 1000 tablets $0.024 — Availability likely
Clonazepam 1 mgNDC 16729-0137-16 Accord 500 tablets $0.024 AB Availability likely
Clonazepam 2 mgNDC 00093-3213-01 Teva 100 tablets $0.040 AB Availability likely
Clonazepam 2 mgNDC 16729-0138-00 Accord 100 tablets $0.040 AB Availability likely
Clonazepam 2 mgNDC 43547-0408-10 Solco 100 tablets $0.040 AB Availability likely
Clonazepam 2 mgNDC 50268-0175-15 AvPAK 50 tablets $0.040 AB Availability likely
Clonazepam 2 mgNDC 59651-0724-01 Aurobindo 100 tablets $0.040 — Availability likely
Clonazepam 2 mgNDC 62135-0771-90 Chartwell 90 tablets $0.040 AB Availability likely
Clonazepam 2 mgNDC 72603-0309-01 Northstar 100 tablets $0.040 — Availability likely
Klonopin 1 mgNDC 61269-0610-10 H2-Pharma, 100 tablets $3.054 +12426% AB Availability likely
Klonopin 2 mgNDC 61269-0620-10 H2-Pharma, 100 tablets $4.247 +10473% AB Availability likely
Clonazepam 2 mgNDC 43063-0788-30 PD-Rx 30 tablets — AB FDA listed
Clonazepam 2 mgNDC 58118-0154-08 Clinical 30 tablets — — FDA listed
Clonazepam 2 mgNDC 63629-1206-01 Bryant 100 tablets — AB FDA listed
Clonazepam 2 mgNDC 63629-1207-01 Bryant 500 tablets — AB FDA listed
Clonazepam 2 mgNDC 67046-1488-03 Coupler 30 tablets — — FDA listed
Clonazepam 2 mgNDC 68071-3613-06 NuCare 60 tablets — AB FDA listed
Clonazepam 2 mgNDC 68788-8499-02 Preferred 20 tablets — AB FDA listed
Clonazepam 2 mgNDC 70518-2232-00 REMEDYREPACK 100 tablets — AB FDA listed
Clonazepam 2 mgNDC 70518-3849-00 REMEDYREPACK 100 tablets — AB Discontinued
Clonazepam 2 mgNDC 71335-0333-01 Bryant 30 tablets — AB Discontinued

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Clonazepam Tablet — that fall in the same broad treatment class (anticonvulsant - benzodiazepine type) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 004562
GCN 17472
HICL code 001894
Ingredient (HICL) Clonazepam
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H4
Therapeutic class — intermediate (HIC2) Anticonvulsants
HIC3 code H4A
Therapeutic class — specific (HIC3) Anticonvulsant - Benzodiazepine Type
AHFS code 28:12.08.00
AHFS class Benzodiazepines (Anticonvulsants)
FDB label name CLONAZEPAM 2 MG TABLET
FDB brand name Clonazepam
Legend status F — Federal legend — prescription drug or device
GPI-1472100010000315
GPI classclonazePAM
DEA scheduleCIV
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Clonazepam Tablet shortage FAQs

Is Clonazepam Tablet in shortage?
Yes — the FDA currently lists Clonazepam Tablet in shortage (status: “Current”, first reported Mar 10, 2023). 40 of 40 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Why is Clonazepam Tablet in shortage?
The manufacturer-reported reason on file with the FDA: Other. Estimated supply: August 2026.
Which products are affected?
Clonazepam, Tablet, 2 mg (NDC 16729-138-00) (NDC 16729-0138-00); Clonazepam, Tablet, 1 mg (NDC 16729-137-00) (NDC 16729-0137-00); Clonazepam, Tablet, 1 mg (NDC 16729-137-16) (NDC 16729-0137-16). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Clonazepam Tablet be available again?
The manufacturer reports: Estimated supply: August 2026. The FDA does not publish a single guaranteed restock date — confirm with your pharmacy.
Can I still get Clonazepam somewhere?
Other manufacturers (Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals, PD-Rx Pharmaceuticals, Inc. and others) still market it and have not reported a shortage. See “Where else can I get Clonazepam Tablet?” above — stock still varies by pharmacy.
What should I do if I take Clonazepam Tablet?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out. Because this is a controlled substance, transfers and substitutions have extra federal/state rules — ask the pharmacy first.

Still have a question about the Clonazepam Tablet shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages